Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 229 | $40,153,436 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Jan 2023 16:33 | PCVX | Vaxcyte Inc | LUKATCH HEATH | Director | 10 Jan 2023 | Sale | 233 | 46.0413 | 10,728 | D |
05 Feb 2024 17:33 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 Feb 2024 | Sale | 134 | 71.931 | 9,639 | I |
05 Sep 2024 17:13 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 03 Sep 2024 | Sale | 80 | 117.28 | 9,382 | D |
27 Feb 2024 16:17 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 23 Feb 2024 | Sale | 119 | 77.56 | 9,230 | D |
03 May 2024 16:20 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 01 May 2024 | Sale | 144 | 63.903 | 9,202 | D |
05 Sep 2024 17:13 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 03 Sep 2024 | Sale | 79 | 114.96 | 9,082 | D |
04 Jan 2024 16:26 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, Gen Counsel & Corp Sec | 02 Jan 2024 | Sale | 141 | 62.912 | 8,871 | D |
05 Jun 2024 16:56 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 03 Jun 2024 | Sale | 117 | 73.46 | 8,595 | I |
02 Jul 2024 16:16 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 01 Jul 2024 | Sale | 111 | 77.215 | 8,571 | D |
05 Feb 2024 17:33 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 Feb 2024 | Sale | 119 | 71.934 | 8,560 | I |
28 Sep 2022 18:23 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 26 Sep 2022 | Sale | 319 | 25.281 | 8,065 | I |
04 Jan 2024 16:24 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 02 Jan 2024 | Sale | 127 | 62.93 | 7,992 | I |
04 Jan 2024 16:25 | PCVX | Vaxcyte Inc | WASSIL JIM | Chief Operating Officer | 02 Jan 2024 | Sale | 110 | 65.15 | 7,167 | D |
20 Dec 2023 16:35 | PCVX | Vaxcyte Inc | GUGGENHIME ANDREW | President and CFO | 18 Dec 2023 | Sale | 117 | 60.79 | 7,112 | D |
22 Nov 2023 16:51 | PCVX | Vaxcyte Inc | GUGGENHIME ANDREW | President and CFO | 20 Nov 2023 | Sale | 124 | 51.95 | 6,442 | D |
04 Jan 2024 16:24 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 02 Jan 2024 | Sale | 97 | 62.911 | 6,102 | I |
03 Nov 2023 16:30 | PCVX | Vaxcyte Inc | WASSIL JIM | Chief Operating Officer | 01 Nov 2023 | Sale | 122 | 48.119 | 5,871 | D |
28 Sep 2022 18:23 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 26 Sep 2022 | Sale | 227 | 25.299 | 5,743 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 72 | 63.87 | 4,599 | I |
12 Jan 2023 16:33 | PCVX | Vaxcyte Inc | LUKATCH HEATH | Director | 10 Jan 2023 | Sale | 82 | 46.3274 | 3,799 | D |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 46 | 63.84 | 2,937 | I |
05 Aug 2024 16:10 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 01 Aug 2024 | Sale | 23 | 79.47 | 1,828 | D |
19 Jan 2024 16:17 | PCVX | Vaxcyte Inc | GUGGENHIME ANDREW | PRESIDENT AND CFO | 18 Jan 2024 | Sale | 23 | 63.35 | 1,457 | D |
05 Sep 2024 17:19 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 03 Sep 2024 | Sale | 10 | 117.025 | 1,170 | D |
14 Dec 2022 17:03 | PCVX | Vaxcyte Inc | LUKATCH HEATH | Director | 12 Dec 2022 | Sale | 16 | 42.365 | 678 | D |
05 Sep 2024 17:13 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 03 Sep 2024 | Sale | 4 | 107.67 | 431 | D |
03 Apr 2024 16:21 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 3 | 68.1 | 204 | I |
03 Nov 2023 16:29 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 01 Nov 2023 | Sale | 3 | 48.1 | 144 | I |
03 Nov 2023 16:29 | PCVX | Vaxcyte Inc | PICKERING GRANT | Chief Executive Officer | 01 Nov 2023 | Sale | 3 | 48.1 | 144 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)